Medical News

Tumor Infiltrating Neutrophil Might Play a Major Role in Pre...
BMC Cancer

In this study, higher TIN after NACT was confirmed to be associated with breast cancer patients’ worse chemotherapy...

15 Jan 2021

Ultra-hypofractionated versus Conventionally Fractionated Ra...
Lancet Oncol.

Although acute toxicity was higher for ultra-hypofractionation than conventional fractionation, this long-term...

12 Jan 2021

Guideline-concordant Treatment Predicts Survival: A National...
Breast Cancer

In this large national study of CoC facilities, two composite scores capturing guideline-concordant breast cancer...

07 Jan 2021

Insulinemic and Inflammatory Dietary Patterns and Risk of Pr...
Eur Urol.

Hyperinsulinemia and inflammation may be potential mechanisms linking dietary patterns with the risk of aggressive...

07 Jan 2021

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

 
Email this page

Key Trials

Oncological and Functional Outcomes with High-Intensity Focused Ultrasound in the Treatment of Prostate Cancer

Partial-gland high-intensity focused ultrasound (HIFU) was safer than whole-gland HIFU, and they had similar oncological outcomes. More prospective...

Lapatinib plus Capecitabine versus Capecitabine Alone in Women with Progressive HER2-positive in Locally Advanced or Metastatic Breast Cancer

The present study compared lapatinib plus capecitabine with capecitabine alone in women with progressive, HER2-positive, locally advanced or...

Clinical Efficacy of Lapatinib Combined with Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast Cancer

This trial compared the combination of letrozole plus lapatinib with letrozole plus placebo as first-line treatment of patients with HR-positive MBC...

Efficacy of 6 Months of Capecitabine vs. 12 Months as Adjuvant Chemotherapy for Patients with Stage III CRC

This is the first phase III trial on postoperative adjuvant chemotherapy in which the duration of oral 5-fluoropyrimidine drug for colorectal cancer...

Patient Education

All You Wanted to Know About Thyroid Cancer

Thyroid cancer is relatively uncommon compared to other cancers. This input describes the risk factors, symptoms, diagnosis and over all treatment fo...

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer giv...

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
44% (4 votes)
Tegafur uracil
0% (0 votes)
5-FU
56% (5 votes)
Total votes: 9